American Cannabis Company, Inc. Discusses Its 2020 Strategy with The Stock Day Podcast
February 27, 2020 11:29 AM EST | Source: Stock Day Media
Phoenix, Arizona--(Newsfile Corp. - February 27, 2020) - The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) ("the Company"), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO and Director of the Company, Terry Buffalo, joined Stock Day host Sharon Lee.
Lee began the interview by asking Buffalo about the Company's background and current projects. "American Cannabis has been around for about seven years, and we are a seed-to-sale consulting company," explained Buffalo. "We go into new markets helping clients with their application work and business plan," he continued, adding that the Company will also assist with the build-out and deployment of their client's facilities as well as operational management.
Lee then commented on the Company's financials throughout 2019, and asked about the factors that contributed to their revenue increases. Buffalo noted that the Company was able to take on additional revenue by working with multiple clients in the emerging markets of both Missouri and Illinois. "In 2020, hopefully we will have 6 to 7 new markets that are coming onboard, which will contribute to our 2020 progress going forward," said Buffalo.
The conversation then turned to a discussion about the contraction of cannabis stock prices and the opportunity it represents for the Company. "You have companies that are not doing enough due diligence," explained Buffalo, noting that many companies in the cannabis industry are not keeping up to date with their financials. "They're just running kind of free to make acquisitions for top-line numbers," he added. "Now the market is changing; you have investors who actually want a return on their money," said Buffalo. "We're going to continue seeing it be very challenging in the capital markets for private and public companies to be able to raise capital going forward," he continued.
"How do you see American Cannabis taking advantage of this?", asked Lee. "We've been very strategic and methodical," shared Buffalo. He explained that one of the Company's Missouri clients, CannCare, is looking to diversify their holdings in other markets. "We're vetting a couple of deals with them currently. We hope that we will have some of those deals inked in the next couple of weeks," said Buffalo. He also explained the Company's recent strategic S1 filing in 2019, stating that the Company will "…have the liquidity available to us when the opportunities do present themselves."
Lee then asked about the Company's all natural, fully amended potting mix, SoHum Living Soils® ("SoHum"). "With SoHum in general, it's a very clean product," said Buffalo, noting that consumers are becoming more and more concerned with what they are ingesting and how products are developed or grown. "The other thing about SoHum is that it enables you to lower your costs tremendously," explained Buffalo. "This is basically a product that from start all the way through harvest you need to add nothing but water. So, it helps to eliminate human error and labor costs," said Buffalo.
To close the interview, Buffalo expressed the Company's excitement for their future projects. "We do have a very clean balance sheet; we have no debt on our books, which is a rarity for the cannabis space," said Buffalo. "We're going to be very methodical as we're looking at these acquisitions that we're trying to bring under our company umbrella," he added. "Again, we'll be trying to bring some additional cash flow and positive numbers, which will also bring shareholder value."
To watch the entire interview with American Cannabis Company, follow the link to the video here: https://www.youtube.com/watch?v=8DcmIOYsrps&feature=youtu.be
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About American Cannabis Company, Inc.
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and furthermore, the firm has become more involved with taking equity positions in client projects, licensing the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® - Winner of the High Times S.T.A.S.H Award for "Best Potting Mix", The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.
For more information, please visit:
www.theacclife.com
www.americancannabisconsulting.com
www.sohumsoils.com
www.americanhempservices.com
Forward-Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law
Cannabis and its derivatives are considered illegal "Schedule 1" drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.
Contact:
IR@americancannabisconsulting.com
303-974-4770
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
SOURCE:
Stock Day Media
602-441-3474
Disclaimer
Stock Day Media publishes general information about our featured companies, and a basis for conducting due diligence. The general information we publish is based upon sources we believe to be trustworthy. However, you should always conduct your own due diligence on any company when considering whether or not to make an investment. Claims of past performance are no guarantee of future performance. Apart from the general information we publish about our featured companies, we may sometimes provide our own opinions about the industries and markets our featured companies do business in. All of the opinions we may make are our own, and must not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of our featured companies are solely your own responsibility based on your own due diligence. Our publications about our featured companies are provided only as an informational aid, and as a starting point for doing additional independent research and due diligence. We also recommend, as a general rule, that before investing in any security you should consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks.
Our featured companies compensate us for our publication services. We only accept cash consideration in exchange for our publication, and do not accept any form of equity compensation, either from our company clients or company-related third parties. We do not buy, sell or hold any securities in the companies we feature.
17b Disclosure
Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we entered into a contract with American Cannabis Company, Inc. wherein we agreed to publish a podcast about the Company. In exchange for our services, the Company compensated us with $1,800.00.
We are not a registered broker, dealer, analyst, or adviser. We hold no investment licenses and may not sell, offer to sell or offer to buy any security. Our publications about our featured companies are not a recommendation to buy or sell any security.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52895